Discover the SciOpen Platform and Achieve Your Research Goals with Ease.
Search articles, authors, keywords, DOl and etc.
Ali MAM. Chronic myeloid leukemia in the era of tyrosine kinase inhibitors: An evolving paradigm of molecularly targeted therapy. Mol Diagn Ther. 2016;20(4):315–333.
Alves R, Gonçalves AC, Rutella S, et al. Resistance to tyrosine kinase inhibitors in chronic myeloid leukemia-from molecular mechanisms to clinical relevance. Cancers. 2021;13(19):4820.
Koh Y, Kim DY, Park SH, et al. Increased BCR promoter DNA methylation status strongly correlates with favorable response to imatinib in chronic myeloid leukemia patients. Oncol Lett. 2011;2(1):181–187.
Gilpatrick T, Lee I, Graham JE, et al. Targeted nanopore sequencing with Cas9-guided adapter ligation. Nat Biotechnol. 2020;38(4):433–438.
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).